We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks Investment Ideas feature highlights: Church & Dwight, Eli Lilly and Viatris
Read MoreHide Full Article
For Immediate Release
Chicago, IL – September 4, 2025 – Today, Zacks Investment Ideas feature highlights Church & Dwight (CHD - Free Report) , Eli Lilly (LLY - Free Report) and Viatris (VTRS - Free Report) .
Insider Watch: 3 CEOs Buying the Dip
Investors closely monitor insider buys, as they can give hints surrounding the long-term picture.
But it’s critical to note that insiders have a longer holding period than most, and many strict rules apply to their transactions.
Recently, CEOs of several companies – Church & Dwight, Eli Lilly and Viatris – have made splashes, acquiring shares. Let’s take a closer look at the transactions for those interested in trading like the insiders.
CHD CEO Buys $500K Worth
Church & Dwight develops, manufactures, and markets a broad range of household, personal care, and specialty products. The CEO dove in near mid-August, purchasing roughly 5.5k CHD shares at an overall transaction cost of just over $500k.
Shares have outperformed big in 2025 so far, losing roughly 10%. Still, insiders have been busy buying the dip, with the green arrows circled in the chart representing net insider buying activity.
LLY CEO Buys Post-Earnings Weakness
LLY shares have faced pressure in 2025 so far, down 5% overall and widely underperforming relative to the S&P 500. But shares have shown nice life off the post-earnings lows so far, with insiders also buying after selling all throughout the year.
VTRS Insiders Buy On Momentum
Viatris, a global healthcare company, boasts an extensive product portfolio that comprises more than a thousand approved molecules across a wide range of key therapeutic areas. CEO Scott Smith made a sizable purchase, acquiring 22k VTRS shares at an overall transaction cost of roughly $220k.
Like those above, VTRS shares have lagged the S&P 500 considerably in 2025, down roughly 12%. But as shown again, insiders have been busy scooping up shares at discounted levels.
Bottom Line
Many investors closely monitor insider buys, seeking insights into the longer-term picture. The transactions shouldn’t be relied on for near-term performance, as insiders’ holding periods are longer than most, and many strict rules apply.
Rather, investors can see insider buys as an overall net positive concerning the longer-term outlook.
All large-cap stocks above have seen their respective CEOs make purchases over the last month.
Free: Instant Access to Zacks' Market-Crushing Strategies
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can tap into those powerful strategies – and the high-potential stocks they uncover – free. No strings attached.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks Investment Ideas feature highlights: Church & Dwight, Eli Lilly and Viatris
For Immediate Release
Chicago, IL – September 4, 2025 – Today, Zacks Investment Ideas feature highlights Church & Dwight (CHD - Free Report) , Eli Lilly (LLY - Free Report) and Viatris (VTRS - Free Report) .
Insider Watch: 3 CEOs Buying the Dip
Investors closely monitor insider buys, as they can give hints surrounding the long-term picture.
But it’s critical to note that insiders have a longer holding period than most, and many strict rules apply to their transactions.
Recently, CEOs of several companies – Church & Dwight, Eli Lilly and Viatris – have made splashes, acquiring shares. Let’s take a closer look at the transactions for those interested in trading like the insiders.
CHD CEO Buys $500K Worth
Church & Dwight develops, manufactures, and markets a broad range of household, personal care, and specialty products. The CEO dove in near mid-August, purchasing roughly 5.5k CHD shares at an overall transaction cost of just over $500k.
Shares have outperformed big in 2025 so far, losing roughly 10%. Still, insiders have been busy buying the dip, with the green arrows circled in the chart representing net insider buying activity.
LLY CEO Buys Post-Earnings Weakness
LLY shares have faced pressure in 2025 so far, down 5% overall and widely underperforming relative to the S&P 500. But shares have shown nice life off the post-earnings lows so far, with insiders also buying after selling all throughout the year.
VTRS Insiders Buy On Momentum
Viatris, a global healthcare company, boasts an extensive product portfolio that comprises more than a thousand approved molecules across a wide range of key therapeutic areas. CEO Scott Smith made a sizable purchase, acquiring 22k VTRS shares at an overall transaction cost of roughly $220k.
Like those above, VTRS shares have lagged the S&P 500 considerably in 2025, down roughly 12%. But as shown again, insiders have been busy scooping up shares at discounted levels.
Bottom Line
Many investors closely monitor insider buys, seeking insights into the longer-term picture. The transactions shouldn’t be relied on for near-term performance, as insiders’ holding periods are longer than most, and many strict rules apply.
Rather, investors can see insider buys as an overall net positive concerning the longer-term outlook.
All large-cap stocks above have seen their respective CEOs make purchases over the last month.
Free: Instant Access to Zacks' Market-Crushing Strategies
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can tap into those powerful strategies – and the high-potential stocks they uncover – free. No strings attached.
Get all the details here >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.